Skip to main content
Terug
Watch Compare

BrightSpring Health Services, Inc.

Datakwaliteit: 100%
BTSGU
Nasdaq Services Health Services
€ 150,89
▼ € 4,13 (-2,66%)
Marktkapitalisatie: 34,07 B
Prijs
€ 155,02
Marktkapitalisatie
34,07 B
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

ROE of 10,71% — decent returns on equity
Generating 394,69 M in free cash flow
P/E of 178,69 — premium valuation
Cash machine — converts 207,00% of earnings into free cash flow
Capital efficient — spends only 0,74% of revenue on capex
Interest coverage of 1,88× — tight debt servicing

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)14,59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
10,71%
Boven sectorgemiddelde (-15,85%)
ROIC5,02%
Net Margin1,48%
Op. Margin2,29%

Veiligheid

Debt / Equity
1,38
Boven sectorgemiddelde (0,39)
Current Ratio1,79
Interest Coverage1,88

Waardering

PE (TTM)
178,69
Boven sectorgemiddelde (-1,21)
P/B Ratio18,73
EV/EBITDA79,31
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (506 peers)
Metriek Aandeel Sector Mediaan
P/E 178,7 -1,2
P/B 18,7 1,4
ROE % 10,7 -15,8
Net Margin % 1,5 -18,3
Rev Growth 5Y % — 4,0
D/E 1,4 0,4

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 — 16,70 B —
FY2026 — 14,84 B —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 14,59% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 12,91 B Net Income (TTM) 190,67 M
ROE 10,71% ROA 3,18%
Gross Margin 11,76% Operating Margin 2,29%
Net Margin 1,48% Free Cash Flow (TTM) 394,69 M
ROIC 5,02% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,38 Current Ratio 1,79
Interest Coverage 1,88 Asset Turnover 2,15
Working Capital 1,23 B Tangible Book Value -1,07 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 178,69 Forward P/E N/A
P/B Ratio 18,73 P/S Ratio 2,64
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 79,31 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1,16%
Market Cap 34,07 B Enterprise Value 36,45 B
Per Share
EPS (Diluted TTM) 0,87 Revenue / Share 58,74
FCF / Share 1,80 OCF / Share 2,23
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,74% FCF Conversion 207,00%
SBC-Adj. FCF 314,10 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 12,91 B 11,27 B
Net Income 190,67 M -18,06 M
EPS (Diluted) 0,87 -0,09
Gross Profit 1,52 B 1,59 B
Operating Income 295,25 M 206,37 M
EBITDA — —
R&D Expenses — —
SG&A Expenses 1,22 B 1,38 B
D&A 164,28 M 204,48 M
Interest Expense 157,31 M 228,39 M
Income Tax 33,15 M -14,22 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 6,41 B 5,93 B
Total Liabilities 4,53 B 4,27 B
Shareholders' Equity 1,88 B 1,65 B
Total Debt 2,51 B 2,61 B
Cash & Equivalents 88,37 M 61,25 M
Current Assets 2,89 B 1,89 B
Current Liabilities 1,85 B 1,43 B